EE158 Healthcare Resource Utilization and Costs Among Medicare Beneficiaries Initiating Venetoclax Vs. Btkis for Relapsed/Refractory Chronic Lymphocytic Leukemia: A Real-World Study

Autor: Huntington, S., Manzoor, B.S., Jawaid, D., Puckett, J., Alhasani, H., Ravelo, A., Kamal-Bahl, S., Emechebe, N., Doshi, J.A.
Zdroj: In Value in Health June 2023 26(6) Supplement:S88-S89
Databáze: ScienceDirect